Fig. 1From: A robust prognostic gene expression signature for early stage lung adenocarcinomaKaplan-Meier overall or recurrence-free survival estimates for seven early stage lung adenocarcinoma cohorts and the TCGA LUAD validation cohort [4–10, 16]. Each cohort was split according to ESLA-7 score (red: > median, black: ≤ median)Back to article page